Schedule of Restricted Stock Award Activity (Details) - Restricted Stock Units (RSUs) [Member]	3 Months Ended
	Mar. 31, 2022 $ / shares shares
2014 Long Term Incentive Equity Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Stock Options Outstanding, Beginning Balance | shares	1,566,666
Weighted Average Grant Date Fair Value, Outstanding, Beginning Balance | $ / shares	$ 2.31
Number of Stock Options, Granted | shares		[1]
Weighted Average Grant Date Fair Value, Granted | $ / shares
Number of Stock Options, Released | shares	(466,666)
Weighted Average Grant Date Fair Value, Released | $ / shares	$ 1.06
Number of Stock Options, Forfeited | shares	(150,000)
Weighted Average Grant Date Fair Value, Forfeited | $ / shares	$ 2.04
Number of Stock Options Outstanding, Ending Balance | shares	950,000
Weighted Average Grant Date Fair Value, Ending Balance | $ / shares	$ 2.97
2018 Long Term Incentive Equity Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Stock Options Outstanding, Beginning Balance | shares	1,890,740
Weighted Average Grant Date Fair Value, Outstanding, Beginning Balance | $ / shares	$ 12.94
Number of Stock Options, Granted | shares	320,000
Weighted Average Grant Date Fair Value, Granted | $ / shares	$ 4.53
Number of Stock Options, Released | shares
Weighted Average Grant Date Fair Value, Released | $ / shares
Number of Stock Options, Forfeited | shares
Weighted Average Grant Date Fair Value, Forfeited | $ / shares
Number of Stock Options Outstanding, Ending Balance | shares	2,210,740
Weighted Average Grant Date Fair Value, Ending Balance | $ / shares	$ 11.07

[1] Stock options granted under the Lucid Diagnostics Inc. 2018 Equity Plan generally vest ratably over twelve quarters, with the vesting commencing with the grant date quarter, and have a ten-year contractual term from date-of-grant.